Navigation Links
Market Publishers Ltd and GenericsWeb Sign Partnership Agreement
Date:12/27/2010

LONDON, Dec. 27, 2010 /PRNewswire/ -- Market Publishers Ltd and GenericsWeb Pty Ltd signed partnership agreement for quality market research promotion on Internet. MarketPublishers.com is now authorized to distribute and sell GenericsWeb research reports.

Mrs. Alla Martin, Head of Partner Relations Department, mentioned in her comments on the agreement: "GenericsWeb is a highly professional company whose title speaks for itself – the company focuses on the pipeline products, new drugs developments, and extended patent information. We are sure that our clients will develop much interest in the products offered by GenericsWeb, among which there are regularly updated news and articles, business intelligence, industry links, product development services and e-newsletters."

In-demand market reports by GenericsWeb:

  • Repaglinide - Comprehensive Patent Search
  • Ribavirin - Comprehensive Patent Search
  • Riluzole - Comprehensive Patent Search
  • Rimonabant - Comprehensive Patent Search
  • Risedronic Acid - Comprehensive Patent Search
  • Risperidone - Comprehensive Patent Search
  • Ritonavir - Comprehensive Patent Search
  • Rituximab - Comprehensive Patent Search
  • Rivaroxaban - Comprehensive Patent Search
  • Rivastigmine - Comprehensive Patent Search

  • Each of the above mentioned reports is a regularly updated, professional patent search which not only identifies relevant patents, but delivers categorisation and interpretation, all delivered by a convenient online interface.

    Each Patent Search features:

  • Comprehensive patent searching, covering the world's key territories;
  • Identifies patents covering molecule, formulation, process, use, combination and assay techniques;
  • Patent identification, categorisation and interpretation;
  • Grouped by patent family and assigned to development categories based on Interpretation of key aspects of the patent claims;
  • Manual filtration of patents not relevant to generic development;
  • Updated on a monthly basis, including changes to patent families, statuses, and litigation;
  • Enables fast analysis and verification by hyper-linking to crucial patent documents and national registers.

  • More details on GenericsWeb and their reports can be found at http://marketpublishers.com/members/genericsweb/info.htmlCONTACTS The Market Publishers, Ltd.Mrs. Alla MartinTel: +44 208 144 6009Fax: +44 207 900 3970ps@marketpublishers.comwww.marketpublishers.com
    '/>"/>

    SOURCE The Market Publishers Ltd
    Copyright©2010 PR Newswire.
    All rights reserved

    Related medicine technology :

    1. Ranbaxy Receives Approval to Manufacture and Market Hydrocodone Bitartrate and Acetaminophen Tablets USP
    2. FDA Advisory Committees Recommend Continued U.S. Marketing Authorization for Trasylol(R)
    3. Oncology Drugs Development Update - Worldwide Markets and Forecasts of Approved EGFr/HEr2 Inhibitors, Treatment Costs, Pathway Analysis, Current and Expanded Clinical Indications, and Novel Agents in Development
    4. ADVENTRX Announces Completion of Patient Enrollment in ANX-530 Marketing-Enabling Clinical Study
    5. Results of TRIUMPH-1 Trial of Viveta in Pulmonary Arterial Hypertension to Be Announced Before Market Open on Thursday, November 1, 2007
    6. Inverness Medical Innovations to Present at CIBC World Markets 18th Annual Healthcare Conference on November 7, 2007
    7. ADVENTRX Meets Primary Endpoint in ANX-530 Marketing-Enabling Clinical Study
    8. Poniard Pharmaceuticals Provides Year-End Clinical Update at 2007 Lazard Capital Markets Healthcare Conference
    9. Replidyne to Participate on Anti-infective Panel at RBC Capital Markets Healthcare Conference
    10. GE Healthcare and Novavax Establish Collaboration To Develop and Market Pandemic Influenza Solution
    11. Pharmion Submits European Marketing Authorization Application (MAA) for Vidaza(R) in Patients with Higher-Risk Myelodysplastic Syndromes (MDS)
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:4/19/2017)... Medical Corporation (TSX: CRH) (NYSE MKT: CRHM) (the "Company"), announces that it ... 2017 at the Sheraton Hotel in Toronto, Ontario ... the Company is scheduled to present on Tuesday, May 2 at ... Chairman of the Board, Tony Holler will also attend ... For more details ...
    (Date:4/19/2017)... April 19, 2017 Global Surgical Drainage Device ... tubes used to remove excess liquid and air. The ... urine, bile or lymph. Surgical drains are used in ... as orthopedics surgery, cardiovascular surgery, neurosurgery, plastic surgery etc. ... to prevent accumulation of fluid e.g. blood or pus. ...
    (Date:4/19/2017)... 2017  Sorrento Therapeutics, Inc. (NASDAQ: ... developing new treatments for cancer and other unmet ... previously announced underwritten public offering of 23,625,084 shares ... price of $2.00 per share, before deducting underwriting ... by Sorrento.  The net proceeds to Sorrento from ...
    Breaking Medicine Technology:
    (Date:4/24/2017)... ... April 24, 2017 , ... NEPC ... Public Communication of Education Research Award. The award honors scholars exemplary in their ... recognizes a scholar who has demonstrated the capacity to deepen the public’s understanding ...
    (Date:4/24/2017)... ... ... Bright Pink , a national non-profit organization focusing on the prevention and early detection ... Pink is proud to announce Katie Thiede as their new Chief Executive Officer. In January, ... Chairman of the Board and launched a national search to find a visionary new leader ...
    (Date:4/24/2017)... ... ... Sean Fay is the undisputed king of the infomercial. With clients as ubiquitous ... Grill (which sold more than 100 million units worldwide), he has created more household ... to changes in the broadcast media landscape, the once ever-present infomercial has gone the ...
    (Date:4/24/2017)... ... 2017 , ... The John P. McGovern Museum of Health and Medical Science ... their cognitive health, and share results with their physicians. Members and guests can sign ... website. , BrainCheck founder, Dr. David Eagleman, formerly at Baylor College of Medicine and ...
    (Date:4/24/2017)... ... April 24, 2017 , ... The world-class designers of ... bring their novel lifesaving device for the everyday use of parents worldwide. It ... designed to read a child’s vital signs, and detect unusual symptoms or physical ...
    Breaking Medicine News(10 mins):